HEALTH CATALYST INC. 2023-2024 Proxy Voting Records

Description as filed by funds: Election of three Class II Directors for a term of three years until the 2027 annual meeting of the Stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Daniel Burton

HEALTH CATALYST INC.’s own tally for this item (“Elect Director: Daniel Burton”): 31,119,449 for, 12,090,333 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The Company's stockholders elected each of the three persons named below to serve as a Class II director of the Company to serve a three-year term expiring at the 2027 annual meeting of the stockholders or until their successors are duly elected and qualified, sub…”
Support: 72% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 64 asset managers below reported 17,550,081 for, 2,853,680 withheld, 386,375 abstained.

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

Description as filed by funds: Election of three Class II Directors for a term of three years until the 2027 annual meeting of the Stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: John A. Kane

HEALTH CATALYST INC.’s own tally for this item (“Elect Director: John A. Kane”): 30,312,852 for, 12,896,930 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The Company's stockholders elected each of the three persons named below to serve as a Class II director of the Company to serve a three-year term expiring at the 2027 annual meeting of the stockholders or until their successors are duly elected and qualified, sub…”
Support: 70% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 64 asset managers below reported 17,119,373 for, 3,284,388 withheld, 386,375 abstained.

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

Description as filed by funds: Election of three Class II Directors for a term of three years until the 2027 annual meeting of the Stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Julie Larson-Green

HEALTH CATALYST INC.’s own tally for this item (“Elect Director: Julie Larson-Green”): 30,723,384 for, 12,486,398 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The Company's stockholders elected each of the three persons named below to serve as a Class II director of the Company to serve a three-year term expiring at the 2027 annual meeting of the stockholders or until their successors are duly elected and qualified, sub…”
Support: 71% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 64 asset managers below reported 17,210,880 for, 3,192,881 withheld, 386,375 abstained.

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

Description as filed by funds: To approve, on an advisory, non- binding basis, the compensation of our named executive officers.

HEALTH CATALYST INC.’s own tally for this item (“3. Advisory, Non-Binding Vote to Approve the Compensation of the Company's Named Executive Officers”): 42,599,851 for, 597,262 against — passed, per its Form 8-K filed June 17, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Advisory, Non-Binding Vote to Approve the Compensation of the Company's Named Executive Officers The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company's named executive officers.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 67 managers: 20,850,002 for. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 141 managers: 27,450,215 for, 383,512 against. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF HEALTH CATALYST, INC. FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2024.

HEALTH CATALYST INC.’s own tally for this item (“2. Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm”): 49,068,137 for, 106,662 against — passed, per its Form 8-K filed June 17, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company's consolidated financial statements for the fiscal year ending December 31, 2024.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 67 asset managers below reported 20,850,002 for.

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.